Product Program year 2021 Source: CMS Open Payments

Non-Product Specific

Device None

PDI NonProduct01

Open in the dashboard

General payments

$95,637

40 payments

Research payments

$520,713

5 payments

Through program year 2021, $95,637 in general payments and $520,713 in research payments were reported against Non-Product Specific (None).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $95,637 40
2021 Research $520,713 5

Breakdown

Who paid General payments · program year 2021
  1. Roche Diagnostics Corporation $95,637 40 payments
Top recipients General payments · program year 2021
  1. Robert Redfield Infectious Disease · Baltimore, MD $60,000 63% · 2 payments
  2. St Christophers Hospital For Childr Teaching hospital · PA $8,648 9% · 1 payment
  3. Kathleen Moore Obstetrics & Gynecology · Oklahoma City, OK $4,620 5% · 1 payment
  4. Paulette Mhawech Fauceglia Anatomic Pathology & Clinical Pathology · Austin, TX $4,550 5% · 1 payment
  5. Laura Adhikari Anatomic Pathology & Clinical Pathology · Tulsa, OK $4,550 5% · 1 payment

The top 5 of 37 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Infectious Disease Internal Medicine $60,000 70% · 1 practitioner
  2. Anatomic Pathology & Clinical Pathology Pathology $9,270 11% · 12 practitioners
  3. Emergency Medicine $5,475 6% · 2 practitioners
  4. Obstetrics & Gynecology $4,658 5% · 3 practitioners
  5. Physical Medicine & Rehabilitation $2,900 3% · 1 practitioner

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Maryland $60,021 63% · 2 recipients
  2. Oklahoma $9,170 10% · 2 recipients
  3. Pennsylvania $8,690 9% · 4 recipients
  4. Texas $4,568 5% · 2 recipients
  5. California $3,785 4% · 2 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

40 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record